Increased APLP1 expression and neurodegeneration in the frontal cortex of manganese‐exposed non‐human primates

Chronic manganese (Mn) exposure produces a neurological syndrome with psychiatric, cognitive, and parkinsonian features. Gene expression profiling in the frontal cortex of Cynomologous macaques receiving 3.3–5.0 mg Mn/kg weekly for 10 months showed that 61 genes were increased and four genes were decreased relative to controls from a total of 6766 genes. Gene changes were associated with cell cycle regulation, DNA repair, apoptosis, ubiquitin‐proteasome system, protein folding, cholesterol homeostasis, axonal/vesicular transport, and inflammation. Amyloid‐β (Aβ) precursor‐like protein 1, a member of the amyloid precursor protein family, was the most highly up‐regulated gene. Immunohistochemistry confirmed increased amyloid precursor‐like protein 1 protein expression and revealed the presence of diffuse Aβ plaques in Mn‐exposed frontal cortex. Cortical neurons and white matter fibers from Mn‐exposed animals accumulated silver grains indicative of on‐going degeneration. Cortical neurons also exhibited nuclear hypertrophy, intracytoplasmic vacuoles, and apoptosis stigmata. p53 immunolabeling was increased in the cytoplasm of neurons and in the nucleus and processes of glial cells in Mn‐exposed tissue. In summary, chronic Mn exposure produces a cellular stress response leading to neurodegenerative changes and diffuse Aβ plaques in the frontal cortex. These changes may explain the subtle cognitive deficits previously demonstrated in these same animals.

[1]  Wei Zheng,et al.  Alteration of saliva and serum concentrations of manganese, copper, zinc, cadmium and lead among career welders. , 2008, Toxicology letters.

[2]  V. Rotter,et al.  Amyloid-β precursor-like protein APLP1 is a novel p53 transcriptional target gene that augments neuroblastoma cell death upon genotoxic stress , 2007, Oncogene.

[3]  M. Walsh The global experience with lead in gasoline and the lessons we should apply to the use of MMT. , 2007, American journal of industrial medicine.

[4]  M. Panisset,et al.  Neurobehavioral functioning after cessation of manganese exposure: a follow-up after 14 years. , 2007, American journal of industrial medicine.

[5]  Roberto G Lucchini,et al.  High prevalence of Parkinsonian disorders associated to manganese exposure in the vicinities of ferroalloy industries. , 2007, American journal of industrial medicine.

[6]  Susan M. Resnick,et al.  Resistance to Alzheimer's pathology is associated with nuclear hypertrophy in neurons , 2007, Neurobiology of Aging.

[7]  D. Perl,et al.  The Neuropathology of Manganese-Induced Parkinsonism , 2007, Journal of neuropathology and experimental neurology.

[8]  P. Pasqualetti,et al.  [Metals and oxidative stress in Parkinson's disease from industrial areas with exposition to environmental toxins or metal pollution]. , 2007, Giornale italiano di medicina del lavoro ed ergonomia.

[9]  J. Bergquist,et al.  Irreversible motor impairment in young addicts – ephedrone, manganism or both? , 2007, Acta neurologica Scandinavica.

[10]  T. Guilarte,et al.  Manganese: recent advances in understanding its transport and neurotoxicity. , 2007, Toxicology and applied pharmacology.

[11]  H. Cheong,et al.  Effect of occupational manganese exposure on the central nervous system of welders: 1H magnetic resonance spectroscopy and MRI findings. , 2007, Neurotoxicology.

[12]  Hasan Meral,et al.  Parkinsonism Caused by Chronic Usage of Intravenous Potassium Permanganate , 2007, The neurologist.

[13]  M. Burritt,et al.  Brain metal concentrations in chronic liver failure patients with pallidal T1 MRI hyperintensity , 2006, Neurology.

[14]  T. Guilarte,et al.  Nigrostriatal dopamine system dysfunction and subtle motor deficits in manganese-exposed non-human primates , 2006, Experimental Neurology.

[15]  T. Guilarte,et al.  Evidence for cortical dysfunction and widespread manganese accumulation in the nonhuman primate brain following chronic manganese exposure: a 1H-MRS and MRI study. , 2006, Toxicological sciences : an official journal of the Society of Toxicology.

[16]  T. Guilarte,et al.  Effects of chronic manganese exposure on cognitive and motor functioning in non-human primates , 2006, Brain Research.

[17]  R. Bowler,et al.  Dose–effect relationships between manganese exposure and neurological, neuropsychological and pulmonary function in confined space bridge welders , 2006, Occupational and Environmental Medicine.

[18]  P. Brandt-Rauf,et al.  A Novel Mechanism for p53 to Regulate Its Target Gene ECK in Signaling Apoptosis , 2006, Molecular Cancer Research.

[19]  N. Kumar,et al.  Neuropsychological profiles of manganese neurotoxicity , 2006, European journal of neurology.

[20]  John Calvin Reed,et al.  Regulation of p53 Localization and Activity by Ubc13 , 2006, Molecular and Cellular Biology.

[21]  Carlos Santos-Burgoa,et al.  Motor alterations associated with exposure to manganese in the environment in Mexico. , 2006, The Science of the total environment.

[22]  I. Ferrer,et al.  Interlaboratory Comparison of Assessments of Alzheimer Disease-Related Lesions: A Study of the BrainNet Europe Consortium , 2006, Journal of neuropathology and experimental neurology.

[23]  B. Lai,et al.  Metal exposure and Alzheimer's pathogenesis. , 2006, Journal of structural biology.

[24]  I. Lascu,et al.  DNA sequences acting as binding sites for NM23/NDPK proteins in melanoma M14 cells , 2006, Journal of cellular biochemistry.

[25]  Sanae Nakagawa,et al.  Manganese exposure: neuropsychological and neurological symptoms and effects in welders. , 2006, Neurotoxicology.

[26]  M. Norenberg,et al.  Alzheimer type II astrocytic changes following sub-acute exposure to manganese and its prevention by antioxidant treatment , 2006, Neuroscience Letters.

[27]  Christian Haass,et al.  Amyloid Precursor-like Protein 1 Influences Endocytosis and Proteolytic Processing of the Amyloid Precursor Protein* , 2006, Journal of Biological Chemistry.

[28]  S. Czasch,et al.  A comparison of immunohistochemical and silver staining methods for the detection of diffuse plaques in the aged canine brain , 2006, Neurobiology of Aging.

[29]  W. Deppert,et al.  Transcription-independent pro-apoptotic functions of p53. , 2005, Current opinion in cell biology.

[30]  M. Trenerry,et al.  Neurologic manifestations in welders with pallidal MRI T1 hyperintensity , 2005, Neurology.

[31]  C. Culmsee,et al.  p53 in neuronal apoptosis. , 2005, Biochemical and biophysical research communications.

[32]  F. Ono,et al.  Age‐related changes of intracellular Aβ in cynomolgus monkey brains , 2005, Neuropathology and applied neurobiology.

[33]  M. Kitazawa,et al.  Protein Kinase Cδ Is a Key Downstream Mediator of Manganese-Induced Apoptosis in Dopaminergic Neuronal Cells , 2005, Journal of Pharmacology and Experimental Therapeutics.

[34]  K. Becker,et al.  National Institute on Aging microarray facility--resources for gerontology research. , 2005, The journals of gerontology. Series A, Biological sciences and medical sciences.

[35]  Zhongqi Cheng,et al.  Water Manganese Exposure and Children’s Intellectual Function in Araihazar, Bangladesh , 2004, Environmental health perspectives.

[36]  Hiroshi Murakami,et al.  Negative Regulation of Chk2 Expression by p53 Is Dependent on the CCAAT-binding Transcription Factor NF-Y* , 2004, Journal of Biological Chemistry.

[37]  Y. Thomassen,et al.  Neuropsychological function in manganese alloy plant workers , 2004, International archives of occupational and environmental health.

[38]  T. Südhof,et al.  Cleavage of Amyloid-β Precursor Protein and Amyloid-β Precursor-like Protein by BACE 1* , 2004, Journal of Biological Chemistry.

[39]  Stephen C Bondy,et al.  Oxidative Basis of Manganese Neurotoxicity , 2004, Annals of the New York Academy of Sciences.

[40]  J. Marx Possible Role for Environmental Copper in Alzheimer's Disease , 2003, Science.

[41]  Donna Mergler,et al.  Manganese, monoamine metabolite levels at birth, and child psychomotor development. , 2003, Neurotoxicology.

[42]  J. Kaiser Manganese: A High-Octane Dispute , 2003, Science.

[43]  K. Becker,et al.  Analysis of microarray data using Z score transformation. , 2003, The Journal of molecular diagnostics : JMD.

[44]  M. Kubota,et al.  Whole-blood manganese levels and brain manganese accumulation in children receiving long-term home parenteral nutrition , 2003, Pediatric Surgery International.

[45]  Karl Herrup,et al.  Neuronal Cell Death Is Preceded by Cell Cycle Events at All Stages of Alzheimer's Disease , 2003, The Journal of Neuroscience.

[46]  Ashley I. Bush,et al.  The metallobiology of Alzheimer's disease , 2003, Trends in Neurosciences.

[47]  Barry S. Levy,et al.  Neurologic Effects of Manganese in Humans: A Review , 2003, International journal of occupational and environmental health.

[48]  Christophe Romier,et al.  The NF-YB/NF-YC Structure Gives Insight into DNA Binding and Transcription Regulation by CCAAT Factor NF-Y* , 2003, The Journal of Biological Chemistry.

[49]  Y. Hirata Manganese-induced apoptosis in PC12 cells. , 2002, Neurotoxicology and teratology.

[50]  D. Bredesen,et al.  Caspase cleavage of members of the amyloid precursor family of proteins , 2002, Journal of neurochemistry.

[51]  Y. Sasaki,et al.  Identification of the Osteopontin gene as a direct target of TP53 , 2002, Genes, chromosomes & cancer.

[52]  Yaolin Wang,et al.  Analyses of p53 Target Genes in the Human Genome by Bioinformatic and Microarray Approaches* 210 , 2001, The Journal of Biological Chemistry.

[53]  F. Checler,et al.  The caspase‐derived C‐terminal fragment of βAPP induces caspase‐independent toxicity and triggers selective increase of Aβ42 in mammalian cells , 2001, Journal of neurochemistry.

[54]  C. Pozniak,et al.  Neuronal life and death: an essential role for the p53 family , 2000, Cell Death and Differentiation.

[55]  Y. Kinoshita,et al.  The role of p53 in neuronal cell death , 2000, Cell Death and Differentiation.

[56]  Xiongwei Zhu,et al.  Cyclin' toward dementia , 2000, Journal of neuroscience research.

[57]  S. Chandra,et al.  A second cytotoxic proteolytic peptide derived from amyloid β-protein precursor , 2000, Nature Medicine.

[58]  J. Gitlin,et al.  The Role of Copper in Neurodegenerative Disease , 1999, Neurobiology of Disease.

[59]  T. Hashimoto,et al.  Tremor and seizures associated with chronic manganese intoxication , 1999, Brain and Development.

[60]  B. Hyman,et al.  Immunohistochemical and in situ analysis of amyloid precursor-like protein-1 and amyloid precursor-like protein-2 expression in Alzheimer disease and aged control brains , 1998, Brain Research.

[61]  M. Mesulam,et al.  Infracortical interstitial cells concurrently expressing m2-muscarinic receptors, acetylcholinesterase and nicotinamide adenine dinucleotide phosphate-diaphorase in the human and monkey cerebral cortex , 1998, Neuroscience.

[62]  Sascha Weggen,et al.  Amyloid precursor-like protein 1 accumulates in neuritic plaques in Alzheimer’s disease , 1997, Acta Neuropathologica.

[63]  X. Chen,et al.  p53 is phosphorylated by CDK7-cyclin H in a p36MAT1-dependent manner , 1997, Molecular and cellular biology.

[64]  J. Wands,et al.  Correlates of p53- and Fas (CD95)-mediated apoptosis in Alzheimer's disease , 1997, Journal of the Neurological Sciences.

[65]  A. Levine,et al.  The CDK7-cycH-p36 complex of transcription factor IIH phosphorylates p53, enhancing its sequence-specific DNA binding activity in vitro , 1997, Molecular and cellular biology.

[66]  F. LaFerla,et al.  Extracellular deposition of beta-amyloid upon p53-dependent neuronal cell death in transgenic mice. , 1996, The Journal of clinical investigation.

[67]  I. Black,et al.  Characterization of the genomic structure of the mouse APLP1 gene. , 1996, Genomics.

[68]  T. Shin,et al.  p53 stimulates transcription from the human transforming growth factor alpha promoter: a potential growth-stimulatory role for p53 , 1995, Molecular and cellular biology.

[69]  I. Black,et al.  Selective localization of amyloid precursor-like protein 1 in the cerebral cortex postsynaptic density. , 1995, Brain research. Molecular brain research.

[70]  M. Beal,et al.  Cortical somatostatin, neuropeptide Y, and NADPH diaphorase neurons: Normal anatomy and alterations in alzheimer's disease , 1988, Annals of neurology.

[71]  A. Mathee,et al.  Blood manganese concentrations among first-grade schoolchildren in two South African cities. , 2005, Environmental research.

[72]  M. Evans,et al.  p53 modulation of TFIIH–associated nucleotide excision repair activity , 1995, Nature Genetics.